Navigation Links
Shengtai Pharmaceutical, Inc. Reports Strong Second Quarter Results of Fiscal Year 2008
Date:2/14/2008

36,192,017 42,129,557

COMMITMENTS AND CONTINGENCIES -- --

SHAREHOLDERS' EQUITY:

Preferred stock, $0.001

par value, 5,000,000

shares authorized,

no shares issued and

outstanding -- --

Common stock, $0.001 par

value, 100,000,000 shares

authorized, 19,069,805 and

18,875,000 shares issued and

outstanding as of

December 31, and June 30,

2007, respectively 19,070 18,875

Paid-in capital 19,669,847 19,163,549

Statutory reserves 1,735,484 1,735,484

Retained earnings 15,267,766 9,885,670

Accumulated other

comprehensive income 2,239,649 826,998

Total shareholders' equity 38,931,816 31,630,576

Total liabilities and

shareholders' equity $ 75,123,833 $ 73,760,133

SHENGTAI PHARMACEUTICAL INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF INCOME AND OTHER COMPREHENSIVE INCOME

FOR THE SIX AND THREE MONTHS ENDED DECEMBER 31, 2007 AND 2006

(UNAUDITED)

Three months ended Six months ended

December 31, December 31,

2007 2006 2007 2006

SALES REVENUE $ 24,954,288 $ 12,310,489 $ 44,327,357 $ 22,909,810

COST OF SALES 19,086,274 9,237,442 33,865,306 17,397,319

GROSS PROFIT 5,868,014 3,073,047 10,462,051 5,512,491

SELLING, GENERAL

AND ADMINISTRATIVE

EXPENSES 1,814,376 958
'/>"/>

SOURCE Shengtai Pharmaceutical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. Shengtai Pharmaceutical, Inc. Reports Record 2007 Annual Results
2. Shengtai Pharmaceutical, Inc. Reports First Quarter Results of Fiscal Year 2008
3. Shengtai Pharmaceutical, Inc. to Present at Roth Capital Phoenix Conference
4. Shengtai Pharmaceutical, Inc. to Present at Roth Conference
5. Meretek Diagnostics and Otsuka America Pharmaceutical, Inc. Announce Completion of Merger
6. BD to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
7. Transcept Pharmaceuticals to Present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
8. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at Merrill Lynch 19th Global Pharmaceutical, Biotechnology & Medical Device Conference in New York City
9. MAP Pharmaceuticals to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
10. Arena Pharmaceuticals to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
11. Cardinal Health CEO of Clinical & Medical Products to Speak at Merrill Lynchs Global Pharmaceutical, Biotechnology and Medical Device Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2014)... Diego, CA (PRWEB) September 03, 2014 AttorneyOne.com, ... all the latest information from the FDA on Pedigree ... on August 26, that 22 bags of Pedigree Adult Complete ... to the possible presence of a foreign material. The reason ... metal fragments, which could have entered the packages during the ...
(Date:9/3/2014)... While the Affordable Care Act provides ... the goal of offering better quality care at ... increasing scrutiny of hospital-physician transactions to ensure they ... This increased scrutiny resulted in the first-ever antitrust ... physician practice earlier this year. , ...
(Date:9/3/2014)... LabRoots announces a new educational webinar ... in Translational Diagnostics: Mining and Migrating Robust Cancer ... be airing live September 10, 2014 1:00pm Eastern Time. ... NGS-based biomarker discovery will be introduced, as ... these markers to targeted NGS assays using low-quality (FFPE) ...
(Date:9/3/2014)... (PRWEB) September 03, 2014 Health ... increases patient safety, decreases medical errors, and strengthens ... , To mark the important role health information ... IHS and others across the U.S. have joined ... Week , September 16-20, 2014. With the NHIT ...
(Date:9/3/2014)... 03, 2014 Job seekers who are ... next position can now do both on iHire. By ... a seamless tool for investigating employment and educational opportunities ... online courses) are closing skills gaps and challenging the ... degree programs and brick and mortar universities. To make ...
Breaking Medicine News(10 mins):Health News:Pedigree Adult Complete Nutrition for Dogs Recalled: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:Recent Becker’s Article Addresses Antitrust and Hospital Acquisition of Physician Practices 2Health News:LabRoots Announces New Educational Webinar on Next-Generation Sequencing 2Health News:LabRoots Announces New Educational Webinar on Next-Generation Sequencing 3Health News:Innovative Healthcare Solutions (IHS) Celebrates National Health IT Week September, 15-19, 2014 2Health News:iHire Announces Partnership with MOOCtracks 2
... Clinical Oncology (ASCO) today highlighted several studies in a ... posted online at www.asco.org in advance of ASCO,s 47th ... other major studies will be released in on-site press ... meeting, which is expected to draw approximately 30,000 cancer ...
... receives the Green Mark Platinum Award from the Building ... environmental sustainability. The highest award presented to selected organisations ... towards sustainability. The award goes to NTU,s School ... piece in the centre of the 200-hectare green campus ...
... , WEDNESDAY, May 18 (HealthDay News) -- New research finds ... cancer don,t reduce the average woman,s risk of dying from ... then a transvaginal ultrasound might even cause harm, the University ... of worrisome false-positive results, subsequent biopsies and resulting complications. ...
... of Pittsburgh School of Medicine have developed a mouse model ... rare genetic mutation that appears to cause MDD in the ... published online today in the American Journal of Medical ... clarify the brain events that lead to MDD, and contribute ...
... Reporter , WEDNESDAY, May 18 (HealthDay News) -- The ... the progression of eye problems in people with the ... says. Italian researchers report that they compared daily ... a placebo, and found that selenium could benefit people ...
... 18 (HealthDay News) -- The results of a first prostate-specific antigen ... can predict the risk of dying of prostate cancer within the ... Researchers analyzed blood samples collected from 12,090 Swedish men between 1974 ... nearly 5,000 of the men six years later when they were ...
Cached Medicine News:Health News:ASCO releases studies from upcoming annual meeting 2Health News:ASCO releases studies from upcoming annual meeting 3Health News:NTU wins Platinum Award from BCA for sustainable design 2Health News:Study Finds Ovarian Screening Tests Don't Improve Survival 2Health News:Pitt researchers build a better mouse model to study depression 2Health News:Selenium Might Help Treat Symptoms in Graves' Eye Disease 2Health News:Selenium Might Help Treat Symptoms in Graves' Eye Disease 3Health News:Earlier PSA Test Best Predicts Risk of Dying From Prostate Cancer: Study 2
(Date:9/3/2014)... ,    ... ~   Kiadis Pharma B.V. ... biopharmaceutical company developing T-cell immunotherapy treatments for blood cancers, ... , MD PhD, as its Chief Medical Officer. ... at Ceronco Biosciences. Prior to that he was VP ...
(Date:9/2/2014)... 2014 Reportbuyer.com has added a new ... Technologies for Molecular Imaging Devices ... The objectives of this study are to ... used for diagnostic purposes, present global market measurements ... market segments as well as forecast market and ...
(Date:9/2/2014)... -- Numotion is pleased to announce the appointment of Mark ... Mark is a 30-year retired veteran of GE where ... and was a GE Company Officer since 1999 and a ... running business units within GE Healthcare, with the most recent ... "We are delighted to welcome Mark to our Board," ...
Breaking Medicine Technology:Kiadis Pharma Appoints Jeroen Rovers as its Chief Medical Officer 2Kiadis Pharma Appoints Jeroen Rovers as its Chief Medical Officer 3Kiadis Pharma Appoints Jeroen Rovers as its Chief Medical Officer 4Kiadis Pharma Appoints Jeroen Rovers as its Chief Medical Officer 5Global Markets and Technologies for Molecular Imaging Devices 2Global Markets and Technologies for Molecular Imaging Devices 3Global Markets and Technologies for Molecular Imaging Devices 4Global Markets and Technologies for Molecular Imaging Devices 5Global Markets and Technologies for Molecular Imaging Devices 6Global Markets and Technologies for Molecular Imaging Devices 7Global Markets and Technologies for Molecular Imaging Devices 8Global Markets and Technologies for Molecular Imaging Devices 9Global Markets and Technologies for Molecular Imaging Devices 10Global Markets and Technologies for Molecular Imaging Devices 11Global Markets and Technologies for Molecular Imaging Devices 12Global Markets and Technologies for Molecular Imaging Devices 13Global Markets and Technologies for Molecular Imaging Devices 14Global Markets and Technologies for Molecular Imaging Devices 15Global Markets and Technologies for Molecular Imaging Devices 16Global Markets and Technologies for Molecular Imaging Devices 17Global Markets and Technologies for Molecular Imaging Devices 18Global Markets and Technologies for Molecular Imaging Devices 19Global Markets and Technologies for Molecular Imaging Devices 20Global Markets and Technologies for Molecular Imaging Devices 21Global Markets and Technologies for Molecular Imaging Devices 22Global Markets and Technologies for Molecular Imaging Devices 23Global Markets and Technologies for Molecular Imaging Devices 24Global Markets and Technologies for Molecular Imaging Devices 25
... Tenn., Nov. 18, 2011 MedSolutions , ... services, today announced the launch of its Implantable ... evidence-based guidelines to ensure the clinical appropriateness of ... With the cost of each ICD/CRT-D ...
... Md., Nov. 18, 2011 The U.S. Food and ... ) to treat patients with acute lymphoblastic leukemia (ALL), ... coli derived asparaginase and pegaspargase chemotherapy drugs used ... ) Acute lymphoblastic leukemia is a ...
Cached Medicine Technology:MedSolutions Launches Implantable Cardiac Defibrillator Program to Reduce Unnecessary Surgeries 2MedSolutions Launches Implantable Cardiac Defibrillator Program to Reduce Unnecessary Surgeries 3FDA Approves Erwinaze to Treat a Form of Leukemia 2FDA Approves Erwinaze to Treat a Form of Leukemia 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: